July 8, 2021
Project Profiles Prefilled Apiject Injector

Project Profile: The RiteDose Corporation

In 2020, as part of the U.S. Government’s COVID-19 response, ApiJect entered into a long-term strategic partnership with The Ritedose Corporation (“TRC”). Together, we are able to make operational 45MM units per month of Blow-Fill-Seal fill-finish capacity for America’s COVID-19 response within 7 months at TRC in Columbia, South Carolina.

Might interest you

View All
Global Health
Enhancing Distributed Manufacturing and Vaccine Distribution through Blow-Fill-Seal Prefilled Drug Delivery Platforms, Upcoming Webinar Hosted by Xtalks
Adds BFS platform technology to provide large-scale production capacity for sterile drug dosage forms, including injectables, ophthalmics and inhalation Expands Amneal’s extensive domestic pharmaceutical manufacturing footprint News provided by Xtalks l Feb 10, 2025, 08:30 ET In this free webinar, learn about...
Prefilled Apiject Injector
Transitioning your Drug Product or Vaccine into a Prefilled BFS Delivery Device
• Develop an understanding of the technical factors involved in transitioning your drug product, including material compatibility, process parameters, and their effects on drug stability and integrity. • Identify and resolve potential issues by utilizing prototyping and feasibility studies to ensure the...
BFS Technology
The Blow-Fill-Seal Process
The Blow-Fill-Seal (BFS) process is a widely used manufacturing technique in the pharmaceutical industry. It involves the simultaneous formation, filling, and sealing of containers, all within a single machine. This seamless and efficient process ensures the integrity and sterility of the final...